Bicycle Therapeutics Presents Posters at the SITC 35th Anniversary Annual Meeting

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and…

Zacks Investment Research Upgrades Bicycle Therapeutics (NASDAQ:BCYC) to Hold

Zacks Investment Research upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC) from a sell rating to a hold…

Bicycle Therapeutics (NASDAQ:BCYC) Stock Rating Upgraded by BidaskClub

Bicycle Therapeutics (NASDAQ:BCYC) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in…

Analysts Set Bicycle Therapeutics Limited (NASDAQ:BCYC) PT at $24.80

Bicycle Therapeutics Limited (NASDAQ:BCYC) has been given a consensus recommendation of “Buy” by the eight analysts…

Bicycle Therapeutics Announces Expansion of Scientific Advisory Board

– Four renowned experts join to advise Bicycle as the company advances pipeline of novel cancer…

Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and…

Bicycle Therapeutics Sees Hammer Chart Pattern: Time to Buy? – April 8, 2020

Bicycle Therapeutics plc (BCYC – Free Report)  has been struggling lately, but the selling pressure may be…

Bicycle Therapeutics Announces Pipeline Progress Update

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and…

Bicycle Therapeutics partners with Roche

Bicycle Therapeutics, a Cambridge, UK-based biotech, developing proprietary bicyclic peptides has attracted the attention of Roche…